Carbon-11 PB-12:: An attempt to visualize the dopamine D4 receptor in the primate brain with positron emission tomography

被引:24
作者
Langer, O [1 ]
Halldin, C
Chou, YH
Sandell, J
Swahn, CG
Någren, K
Perrone, R
Berardi, F
Leopoldo, M
Farde, L
机构
[1] Karolinska Hosp, Karolinska Inst, Dept Clin Neurosci, Psychiat Sect, S-17176 Stockholm, Sweden
[2] Turku Pet Ctr, Radiopharmaceut Chem Lab, Turku, Finland
[3] Univ Bari, Dipartimento Farmacochim, Bari, Italy
关键词
dopamine D-4 receptor; C-11]PB-12; PET; brain; primate;
D O I
10.1016/S0969-8051(00)00154-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The dopamine D-4 receptor (D4R) is expressed in low density in various extrastriatal brain regions. This receptor subtype is discussed in relation to the pathophysiology and treatment of schizophrenia but no selective positron emission tomography (PET) ligand is available to date to study the distribution in vivo. The arylpiperazine derivative N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (PB-12) is a never, high affinity (K-i = 0.040 nM) and selective D4R ligand. We radiolabeled PB-12 with carbon-11 (t(1/2) 20.4 min) by O-methylation of the corresponding desmethyl analogue N-[2-[4-(4-chloro phenyl)piperazin-1-yl]ethyl]-3-hydroxybenzamide (LM-190) with [C-11]methyl triflate. Derivative LM-190 was prepared by condensing 3-hydroxybenzoic acid with the appropriate amine. For the radiolabeling, the incorporation yield was >90% and the total synthesis time including high performance liquid chromatography (HPLC) purification was about 35 min, The specific radioactivity of [C-11]PB-12 at time of injection was 67-118 GBq . mu mol(-1). PET studies in a cynomolgus monkey showed a high uptake and widespread distribution of radioactivity in the brain, including the neocortex and thalamus. About 40% of total radioactivity in plasma represented unchanged radioligand at 60 min after injection as determined by HPLC. Pretreatment with the D4R ligand 3-{[4-(4-chlorophenyl)piperazin-1-yl]methyl}-1H-pyrollo[2,3-b]pyridine (L-745,870) prior to radioligand injection failed to demonstrate receptor specific binding in the monkey brain. Furthermore, the brain radioactivity distribution was left unaffected by pretreating with unlabeled PB-12. This failure to detect a D4R-specific signal may be related to a very low density of the D4R in primate brain, insufficient binding affinity of the radioligand, and a high background of nonspecific binding. It can be concluded from these findings that [C-11]PB-12 is not suitable to Visualize the D4R in the primate brain with PET. NUCL MED BIOL 27;8:707-714, 2000. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:707 / 714
页数:8
相关论文
共 48 条
[1]  
[Anonymous], 1995, DEV NUCL MED
[2]   Cellular distribution of the rat D-4 dopamine receptor protein in the CNS using anti-receptor antisera [J].
Ariano, MA ;
Wang, J ;
Noblett, KL ;
Larson, ER ;
Sibley, DR .
BRAIN RESEARCH, 1997, 752 (1-2) :26-34
[3]  
Boy C, 1998, SYNAPSE, V30, P341
[4]   Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies [J].
Defagot, MC ;
Malchiodi, EL ;
Villar, MJ ;
Antonelli, MC .
MOLECULAR BRAIN RESEARCH, 1997, 45 (01) :1-12
[5]   Autoradiographic localization of the putative D4 dopamine receptor in rat brain [J].
Defagot, MC ;
Antonelli, MC .
NEUROCHEMICAL RESEARCH, 1997, 22 (04) :401-407
[6]  
Defagot MC, 2000, J NEUROSCI RES, V59, P202, DOI 10.1002/(SICI)1097-4547(20000115)59:2<202::AID-JNR6>3.0.CO
[7]  
2-5
[8]   Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach [J].
Delforge, J ;
Bottlaender, M ;
Loc'h, C ;
Guenther, I ;
Fuseau, C ;
Bendriem, B ;
Syrota, A ;
Mazière, B .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (05) :533-546
[9]   A PET study of [C-11]FLB 457 binding to extrastriatal D-2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients [J].
Farde, L ;
Suhara, T ;
Nyberg, S ;
Karlsson, P ;
Nakashima, Y ;
Hietala, J ;
Halldin, C .
PSYCHOPHARMACOLOGY, 1997, 133 (04) :396-404
[10]  
Hadley MS, 1996, MED RES REV, V16, P507, DOI 10.1002/(SICI)1098-1128(199611)16:6<507::AID-MED1>3.0.CO